Prophylactic HPV vaccines

AUTOR(ES)

Stanley, Margaret

FONTE

BMJ Group

RESUMO

Two HPV L1 VLP vaccines have been developed, providing protection for at least 5 years and reducing the risk of cervical cancer

Documentos Relacionados

• Assessing the Impact of Prophylactic Vaccines on HPV Prevalence
• Introduction of HPV prophylactic vaccines: a new challenge for Public Health in the 21st century
• HPV vaccines: a controversial issue?
• HPV Vaccines: Separating Myths from Reality
• The role of vaccines in the control of STDs: HPV vaccines.